Nocardia mediterranei produces the antibiotic rifamycin B, which belongs to the ansamycin group. The structure of rifamycin consists of the ansa chain and the chromophore. One part of this chromophore, the seven-carbon amino unit, which initiates ansa chain formation in ansamycins, has been identified as 3-amino-5-hydroxybenzoic acid. Kibby In this paper we describe the isolation and biochemical characterization of an aro~auxo-trophic mutant B9 and the supplementation of mutant A8with potential precursors.
The auxotrophic mutant N. mediterranei B9 described in this paper was first analyzed by auxanography on agar. The minimal medium was supplemented with the three aromatic amino acids (1 %), each alone and in combination and with quinic acid (1 %). The results indicate that mutant B9 has a requirement for the aromatic amino acids in combination. Growth was also observed on quinic acid. Supplementation studies in liquid minimal medium 150 (modified)8) did not confirm the results from auxanography. A slight growth of mutant B9 was also observed whenno supplementwas added to the culture. The supplements (the three aromatic amino acids in combination or quinic acid) increased growth.
The production of rifamycin B by strain B9 was slightly reduced in comparison with the parent in liquid complex medium 1483) (0.2 g/liter for B9 and 0.35 g/liter for parent N8 1 3). In industrial fermentation medium151b2) the rifamycin production of the mutant was higher than with the parent (3.5 g/liter for B9 and 2 g/liter for the parent). Supplementation studies with mutant B9 in this mediumwith all the three aromatic amino acids in combination (2 g/liter each) or with quinic acid (2g/liter) yielded an identical rifamycin B titer of 3.5 g/liter.
Each enzyme activity of the early shikimic acid pathway of the mutant B9 and of the parent N813 was tested in a parallel set of experiments and under the same conditions in crude extracts. The results are summarized in Each supplement was incubated over 10 days at three different concentrations (2.5, 5 and 10 rm). As it was already demonstrated by Ghisalba and Nuesch2) increasing concentrations of 3-amino-5-hydroxybenzoicacid caused a linear stimulation of rifamycin B production. The amount of rifamycin B produced by strain A8 increased from 0.6 g/liter (unsupplemented) to 2. 1 g/liter when supplemented with 10 mM3-amino-5-hydroxybenzoic acid (Fig. 2) . Shikimic acid, quinic acid and their methyl esters (which are believed to penetrate easier into the cell) showed no stimulation of rifamycin B production. Qualitative analysis of culture filtrates by TLC showed that after the fermentation shikimic acid and shikimic acid methyl ester were still present, but quinic acid and quinic acid methyl ester could not be seen. These results indicate that the penetration ofmethylated derivatives of shikimic acid and quinic acid into the cell is not facilitated (Fig. 2) . The supplementation with all three aromatic amino acids in combination at 10 him concentrations caused slight inhibition of rifamycin production (Fig.  2) .
The characterization of the mutants A83) and A104) made it possible to limit the choice of potential precursors for the biosynthesis of 3-amino-5-hydroxybenzoic acid and rifamycin B to DAHP, 3 -dehydroquinic acid, 3-dehydroshikimic acid and shikimic acid. In this paper two different approaches are described which lead to a more precise identification of the precursor. Firstly, a mutant B9 was found which can be characterized as follows: Mutant B9 is aro~(slight growth on minimal medium), 3 Secondly, the supplementation study carried out with mutant A8 showed that even quinic acid which is able to penetrate into the cell did not increase the 
